Cargando…
Antiangiogenesis therapy in ovarian cancer patients: An updated meta-analysis for 15 randomized controlled trials
BACKGROUND: Antiangiogenesis therapy has been demonstrated to prolong the free survival with tolerable toxicity. However the efficacy of these drugs in overall survival (OS) remains controversial. This study was designed to assess the overall performance of antiangiogenesis therapy in improving the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112884/ https://www.ncbi.nlm.nih.gov/pubmed/30142803 http://dx.doi.org/10.1097/MD.0000000000011920 |